Renal ischemia and reperfusion injury: Influence of chorpromazine on renal function and lipid peroxidation

Acta Cirurgica Brasileira

Volumn 23, Issue SUPPL., 2008, Pages 42-46

  Tucci Jr , Silvio ^a   De Carvalho, Roberto Marins ^a   Celini, Fábia Martins ^a   Cologna, Adauto José ^a   Suaid, Haylton Jorge ^a   Tirapelli, Luis Fernando ^a   Martins, Antonio Carlos Pereira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chlorpromazine; Free radicals; Lipid peroxidation; Malondialdehyde; Renal ischemia reperfusion

Indexed keywords

CHLORPROMAZINE; CREATININE; MALONALDEHYDE; NITROGEN; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CLAMP; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; EXPERIMENTAL MODEL; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; LAPAROTOMY; LIPID PEROXIDATION; NONHUMAN; PARTIAL NEPHRECTOMY; POSTOPERATIVE PERIOD; RAT; RENAL PROTECTION; REPERFUSION INJURY; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; CHLORPROMAZINE; CREATININE; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; ISCHEMIA; JAUNDICE, OBSTRUCTIVE; KIDNEY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NEPHRECTOMY; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS; UREA;

EID: 44449083316     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502008000700008     Document Type: Article

References (31)

1. Land W, Messmer K. The impact of ischemia/ reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Transplant Rev. 1996;10:108-11.
2. Gill N, Nally JV Jr, Fatica RA. Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest. 2005;128:2847-63.
3. de Groot H, Rauen U. Ischemia-reperfusion injury: processes in pathogenic networks: a review. Transpl Proc. 2007;39:481-4.
4. Lien YH, Lai LW, Silva AL. Pathogenesis of renal ischemia/reperfusion injury: lessons from knout mice. Life Sci. 2003;74:543-52.
5. McCord JM. Oxygen derived free radicals in post ischemic tissue injury. N Engl J Med. 1985;312:159-63.
6. Stelner MG, Babbs CF. Hydroxyl radical generation by post ischemic rat kidney slices in vitro. Free Radic Biol Med. 1990;9:67-77.
7. Cheeseman KH. Mechanisms and effects of lipid peroxidation. Molec Aspects Med. 1993;14:191-7.
8. Pincemail J, Delfraigne JO, Franssen C, Bonnet P, Deby-Dupont G, Pirenne J, Deby C, Lamy M, Limet M, Merisse M. Evidence for free radical formation during human kidney transplantation. Free Radic Biol Med. 1993;15:343-8.
9. Miller MJ. Preconditioning for cardioprotection against ischemia reperfusion injury: the roles of nitric oxide, reactive oxygen species, heat shock proteins, reactive hyperemia and antioxidants - a mini review. Can J Cardiol. 2001;17:1075-82.
10. Venardo KM, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem. 2007;14:1539-49.
11. Cuzznocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/ reperfusion injury. Pharmacol Ver. 2001;53:135-59.
12. Riksen NP, Oven WJ, Ramkers BP, Van de Broek PH, Engbersen R, Boerman OC, Smits P, Rongen GA. Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans. Clin Pharmacol Ther. 2005;78:52-9.
13. Taniguchi M, Magata S, Suzuki T, Shimamura T, Jin MB, Iida J, Furukawa H, Todo S. Dipyridamole protects the liver against warm ischemia and reperfusion injury. J Am Coll Surg. 2004;198:758-69.
14. Sadis C, Teske G, Stokman G, Kubjak C, Claessen N, Moore F, Loi P, Daillo B, Barvais L, Goldman M, Florquin F, Moine A. Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS ONE. 2007;2:e469.
15. Wagner K, Albrecht S, Neumayer HH. Prevention of post transplant acute tubular necrosis by calcium antagonist diltiazem: a prospective randomized study. Am J Nephrol. 1987;7:287-91.
16. Tucci S Jr, Borelli-Bovo TJ, Cologna AJ, Tiraboschi RB, Martins ACP, Roselino JR. Calcium channel blocker and renal mitochondrial function in warm renal ischemia. Int Braz J Urol. 2005;31:384-9.
17. Anderson CD, Pierce J, Nicoud I, Belous A, Knox CD, Chari RS. Modulation of mitochondrial calcium management attenuates hepatic warm ischemia-reperfusion injury. Liver Transpl. 2005;11:663-8.
18. Kondo N, Kiyomoto H, Yamamoto T, Miyatake A, Sun GP, Rahman M, Hitomi H, Moriwaki K, Hara T, Kimura S, Abe Y, Kohno M, Nishiyama A. Effects of calcium channel blockade on angiotensiII induced peritubular ischemia in rats. J Pharmacol Exp Ther. 2006;316:1047-52.
19. Chien KR, Abrams J, Pfau RG, Farber JL. Prevention by chlorpromazine of ischemic liver cell death. Am J Pathol. 1977;88:539-57.
20. Weight SC, Bell PRF, Nicholson ML. Renal ischemia-reperfusion injury. Br J Surg. 1996;83:162-70.
21. Chien KR, Abrams J, Serroni A, Martin JT, Farber JL. Accelerated phospholipids degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. J Biol Chem. 1978;253:4809-17.
22. Jablonski P, Howden BO, Rae DA, Virrey CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation. 1983;35:198-204.
23. Williams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R. Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Methods. 1997;37:1-7.
24. Netto JMB, Tucci Jr S, Cologna AJ, Suaid HJ, Martins ACP, Molina CAF, Roselino JES. Chlorpromazine and mitochondrial function in kidney ischemia-reperfusion. Acta Cir Bras. 2001;16 (suppl. 1):36-40
25. Else PL, Mansfield K. Activation of sodium transport and intracellular lowering by the neuroleptic drug chlorpromazine. Biochem Pharmacol. 1997;54:275-81.
26. Sader AA, Barbieri-Neto J, Sader SL, Mazzetto SA, Alves P, Vanni JC. The protective action of chlorpromazine on the spinal cord of rabbits submitted to ischemia and reperfusion is dose-dependent. J Cardiovasc Surg. 2002;43:827-31.
27. Edoute Y, van der Merwe EL, Sanan D, Kotze JC, van Niekerk I, Lochner A. Normothermic ischemic cardiac arrest and reperfusion of the isolated working heart: effect of chlorpromazine on functional, metabolic and morphological recovery. J Mol Cell Cardiol. 1983;15:603-20.
28. Farber JL, Martins JT, Chien KR. Irreversible ischemic cell injury. Prevention by chlorpromazine of aggregation of intramembranous particles of rat liver plasma membranes. Am J Pathol. 1978;92:713-32.
29. Esterbauer H, Schaur RJ, Zollner H. Chemistry of hydroxynonenal, malonedialdehyde and related aldehydes. Free Radic Biol Med. 1991;11:81-128.
30. Davenport A, Hopton M, Bolton C. Measurement of malondialdehyde as a marker of oxygen free radical production durenig renal allograft transplantation and the effect on early graft function. Clin Transplant. 1995;9:171-5.
31. Eschwege P, Paradis V, Conti M, Holstege A, Richet F, Deteve J, Menager P, Legrand A, Jardin A, Bedossa P, Benoit G. In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys. J Urol. 1999;162:553-7.